You Searched For "vaccine makers" and got 16 results
Sort By:
1 min read
Danish monkeypox-vaccine maker surges 17% after global health emergency declared
Bavarian Nordic extended its two-day gain to 31% on the WHO news as the company's CEO pledged to pr…
Filip De Mott
2 mins read
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr.
Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfi…
Kelly Cloonan
1 min read
Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business
Novavax shares sank after the COVID-19 vaccine maker warned it has "substantial doubt" about its ab…
Zinya Salfiti
1 min read
Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trial
The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' …
Phil Rosen
3 mins read
China is still racing to develop its own mRNA jabs. But they won't use foreign vaccines to fight COVID because of 'national pride,' says South Korea's top vaccine maker.
After three years of zero-COVID policy, Beijing abruptly rolled back the policy in December, which …
Huileng Tan
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
1 min read
Moderna tanks 14% after COVID-19 vaccine maker cuts yearly sales outlook and misses 3rd-quarter expectations
Short-term supply constraints led Moderna to cut its 2022 revenue outlook to a range of $18 billion…
Carla Mozée
2 mins read
How vaccine-makers are combating variants
These are Business Insider's biggest healthcare stories for February 1.
Lydia Ramsey Pflanzer
2 mins read
Moderna stock plummeted on Biden's support of waiving vaccine patent protections, but that backing won't have a material impact on the company, Morgan Stanley says
"Any new manufacturing operation could take 6-9 months to scale," said Morgan Stanley about compani…
Carla Mozée
2 mins read
Pfizer drops after issuing weaker 2022 outlook, dragging COVID-19 vaccine makers Moderna and Novavax down with it
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…
Matthew Fox
2 mins read
India’s vaccine king Adar Poonawalla will pay $69,000 a week to live on the same neighbourhood as Winston Churchill once did
Poonawalla, who is an alumnus of the University of Westminster, has often referred to London…
2 mins read
Marjorie Taylor Greene, who has boasted about being unvaccinated, owns stock in 3 major vaccine makers
Insider's Conflicted Congress project revealed Greene holds AstraZeneca, Pfizer, and Johnson & John…
Bill Bostock
3 mins read
Bharat Biotech to make antigen for first-ever anti-malaria vaccine
The first dose of the vaccine has reached more than 500,000 children since the pilots we…
2 mins read
Moderna, BioNTech plunge as Bernie Sanders slams 'obscene' profits and tells drug makers to share COVID-19 vaccines with the world
"It's time for these pharmaceutical companies to share their vaccines with the world and start cont…
Matthew Fox
1 min read
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue
The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…
Matthew Fox
2 mins read
Russian vaccine makers are trying to push AstraZeneca COVID-19 vaccine's efficacy to beyond 90%
With the Drug Controller General of India (DCGI) approving Serum Institute of India's 'Covishield' …